BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32286099)

  • 1. Somatic ASXL1 p.R693X mutation identified by next generation sequencing in isolated myeloid sarcoma involving the mediastinum.
    Fang L; Cui Y; Mi Y; Ru K; Sun Q; Qin T; Xu Z; Wang J; Xiao Z
    Curr Med Res Opin; 2020 Jun; 36(6):1003-1007. PubMed ID: 32286099
    [No Abstract]   [Full Text] [Related]  

  • 2. [Isolated myeloid sarcoma involving the mediastinum].
    Jelić-Puskarić B; Kardum-Skelin I; Sustercić D; Pazur M; Vrhovac R; Radić-Kristo D; Gredelj-Simec N; Kovacević DO; Plasćak J; Gasparov S; Jaksić B
    Acta Med Croatica; 2011 Sep; 65 Suppl 1():133-8. PubMed ID: 23126041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years.
    Kaur V; Swami A; Alapat D; Abdallah AO; Motwani P; Hutchins LF; Jethava Y
    Hematology; 2018 Jan; 23(1):17-24. PubMed ID: 28574302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial Analysis and Comparison of Mutation Profiles in Decitabine-treated Myeloid Sarcoma and Subsequent Acute Myeloid Leukemia Using Next-Generation Sequencing.
    Park HS; Son SM; Kwon J
    Ann Lab Med; 2022 Sep; 42(5):602-605. PubMed ID: 35470279
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical molecular testing for ASXL1 c.1934dupG p.Gly646fs mutation in hematologic neoplasms in the NGS era.
    Montes-Moreno S; Routbort MJ; Lohman EJ; Barkoh BA; Kanagal-Shamanna R; Bueso-Ramos CE; Singh RR; Medeiros LJ; Luthra R; Patel KP
    PLoS One; 2018; 13(9):e0204218. PubMed ID: 30222780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediastinal Myeloid Sarcoma with TP53 Mutation Preceding Acute Myeloid Leukemia with a PICALM-MLLT10 Fusion Gene.
    Naesens L; Devos H; Nollet F; Michaux L; Selleslag D
    Acta Haematol; 2018; 140(2):97-104. PubMed ID: 30227397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of next-generation sequencing in diagnosis and monitoring of acute myeloid leukemia and myelodysplastic syndromes.
    Duncavage EJ; Tandon B
    Int J Lab Hematol; 2015 May; 37 Suppl 1():115-21. PubMed ID: 25976969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Using next generation sequencing technology to analyze gene mutations in patients with acute myeloid leukemia and the impact on prognosis].
    Zhao CX; Wang JM; Li JM; Zou SH; Chen FY; Liang AB; Hou J; Hu XX; Zhang YX; Gu SY; Zhu JY; Li P; Du J; Yang YN; Qin YW; Wang XR; Wang C
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3145-3151. PubMed ID: 31694105
    [No Abstract]   [Full Text] [Related]  

  • 9. Case report: Rare myeloid sarcoma development following renal transplantation with KRAS and DNMT3A gene mutations.
    Wu D; Lu X; Yan X; Gao R
    Diagn Pathol; 2021 Aug; 16(1):82. PubMed ID: 34465355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newly diagnosed isolated myeloid sarcoma-paired NGS panel analysis of extramedullary tumor and bone marrow.
    Engel NW; Reinert J; Borchert NM; Panagiota V; Gabdoulline R; Thol F; Heuser M; Fiedler W
    Ann Hematol; 2021 Feb; 100(2):499-503. PubMed ID: 33108522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute myeloid leukemia with mediastinal myeloid sarcoma refractory to acute myeloid leukemia therapy but responsive to L-asparaginase.
    Takahashi H; Koh K; Kato M; Kishimoto H; Oguma E; Hanada R
    Int J Hematol; 2012 Jul; 96(1):136-40. PubMed ID: 22644614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher-risk myelodysplastic syndromes: a prospective multicenter single-arm trial.
    Zhou X; Mei C; Zhang J; Lu Y; Lan J; Lin S; Zhang Y; Kuang Y; Ren Y; Ma L; Wei J; Ye L; Xu W; Li K; Lu C; Jin J; Tong H
    Hematol Oncol; 2020 Oct; 38(4):531-540. PubMed ID: 32469434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia.
    Bera R; Chiu MC; Huang YJ; Lin TH; Kuo MC; Shih LY
    J Hematol Oncol; 2019 Oct; 12(1):104. PubMed ID: 31640815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of ASXL1 mutation in myeloid malignancies].
    Sheng MY; Zhou Y; Xu MJ; Yang FC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1183-7. PubMed ID: 25130853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS.
    Kanagal-Shamanna R; Luthra R; Yin CC; Patel KP; Takahashi K; Lu X; Lee J; Zhao C; Stingo F; Zuo Z; Routbort MJ; Singh RR; Fox P; Ravandi F; Garcia-Manero G; Medeiros LJ; Bueso-Ramos CE
    Oncotarget; 2016 Mar; 7(12):14251-8. PubMed ID: 26883102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of ASXL1 in hematopoiesis and myeloid malignancies.
    Asada S; Fujino T; Goyama S; Kitamura T
    Cell Mol Life Sci; 2019 Jul; 76(13):2511-2523. PubMed ID: 30927018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASXL1 mutations in myeloid neoplasms: pathogenetic considerations, impact on clinical outcomes and survival.
    Alvarez Argote J; Dasanu CA
    Curr Med Res Opin; 2018 May; 34(5):757-763. PubMed ID: 28027687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.
    Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Fu B; Tang G; Goswami M; Singh R; Kanagal-Shamanna R; Pierce SA; Young KH; Kantarjian HM; Medeiros LJ; Luthra R; Wang SA
    Leuk Res; 2015 Mar; 39(3):348-54. PubMed ID: 25573287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.
    Reinig E; Yang F; Traer E; Arora R; Brown S; Rattray R; Braziel R; Fan G; Press R; Dunlap J
    Am J Clin Pathol; 2016 Apr; 145(4):497-506. PubMed ID: 27124934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma.
    Li Z; Stölzel F; Onel K; Sukhanova M; Mirza MK; Yap KL; Borinets O; Larson RA; Stock W; Sasaki MM; Joseph L; Raca G
    Leukemia; 2015 Oct; 29(10):2113-6. PubMed ID: 25787914
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.